Abstract:Celiac disease (CD) is a common systemic disorder that results from an abnormal response of human immunity to gluten intake, affecting the small intestine. In individuals who carry a genetic susceptibility, CD is triggered by environmental factors, including viral infections and dysbiosis of the gut microbiota. The gut microbiome is essential in controlling the immune system, and recent findings indicate that changes in the gut microbiome may contribute to various chronic immune disorders, such as CD through mechanisms that still require further exploration. Some bacteria exhibit epitopes that mimic gliadin and may enhance an immune response in the host. Other bacteria, including Pseudomonas aeruginosa, may work in conjunction with gluten to trigger and escalate intestinal inflammation. The microbiota may also directly influence antigen development through the production of immunogenic or tolerogenic gluten peptides or directly influence intestinal permeability through the release of zonulin. Finally, the gut microbiome can impact intestinal inflammation by generating proinflammatory or anti-inflammatory cytokines and metabolites. It is crucial to consider the impact of genetic factors (specifically, HLA-DQ haplotypes), perinatal elements such as birth mode, type of infant feeding, and antibiotic and infection exposure on the composition of the early intestinal microbiome. According to the available studies, the gut microbiome alterations associated with CD tend to exhibit a decreased presence of beneficial bacteria, including some anti-inflammatory Bifidobacterium species. However, some controversy remains as some reports have found no significant differences between the gut microbiomes of individuals with and without CD. A better understanding of the gut microbiome's role in the development of CD would greatly benefit both prevention and treatment efforts, especially in complicated or treatment-resistant cases. Here, we have attempted to summarize the available evidence on the relationship between the gut microbiota and CD, with a particular focus on potential therapeutic targets.

The Relevance of CD117-Immunocytochemistry Staining Patterns to Mutational Exon-11 in c-kit Detected by PCR from Fine-Needle Aspirated Canine Mast Cell Tumor Cells

Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation

Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder

New Insights into the Pathogenesis of Celiac Disease

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment

New insights on genes, gluten and immunopathogenesis of celiac disease

Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment

Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?

Pathophysiology and immunogenetics of celiac disease

Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity

The Interaction Between Celiac Disease and Intestinal Microbiota

The Role of Intestinal Microbiota in Celiac Disease and Further Therapeutic Perspectives

Beyond the gluten-free diet: Innovations in celiac disease therapeutics

Coeliac disease in childhood: An overview

Potential Make-or-Break Determinants of Celiac Disease

Coeliac Disease and Mast Cells

Celiac Disease: Role of the Epithelial Barrier

Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions